Publications
5674 Results
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#2004
- Year
- 2006
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S0355
A phase I pharmacokinetic (PK) study of the epothilone B analogue, ixabepilone (BMS-247550) in patients (pts) with advanced malignancies and varying degrees of hepatic impairment. a SWOG early therapeutics committee and NCI organ dysfunction working group trial
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7017
- Year
- 2006
- Research Committee(s)
- Lung
- Study Number(s)
- S0339
Bortezomib + gemcitabine (Gem)/carboplatin (Carbo) results in encouraging survival in advanced non-small cell lung cancer (NSCLC): results of a phase II Southwest Oncology Group (SWOG) trial (S0339)
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#9518
- Year
- 2006
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0330
Phase II study of Erlotinib in metastatic or unresectable malignant peripheral nerve sheath tumors (MPNST)
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#4007
- Year
- 2006
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Rtog 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-fu vs. gemcitabine (G) for resected pancreatic adenocarcinoma
- Journal / Conference
- ASCO 2006 Gastrointestinal Cancers Symposium #255
- Year
- 2006
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0336
Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimes for metastatic or locally advanced, unresectable disease: a Southwest Oncology Group study.
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#3598
- Year
- 2006
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0336
Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: a Southwest Oncology Group study
- Journal / Conference
- ASCO 2006 Gastrointestinal Cancers Symposium #144
- Year
- 2006
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Markers of folate metabolism in pancreatic cancer: thymidylate synthase, thymidine phosphorylase, and MTHFR. results from the RTOG 9704 prospective randomized adjuvant treatment trial
- Journal / Conference
- Proc of the ASCO, Journal of Clinical Oncology 24(18S):#4517
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Absolute PSA value after androgen deprivation (AD) is a strong independent predictor of survival in new metastatic (D2) prostate cancer (PCa): Data from Soutwest Oncology Group trial 9346 (INT-0162)
- Journal / Conference
- Proc of the AUA, Journal of Urology 175(4) Suppl:429 (#1333)
- Year
- 2006
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Association of erectile dysfunction and subsequent cardiovascular disease
- Journal / Conference
- Proc of the AUA, Journal of Urology 175(4) Suppl:385-386, (#1197)
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)